DK0673368T3 - Hidtil ukendte nicotinsyreestere - Google Patents

Hidtil ukendte nicotinsyreestere

Info

Publication number
DK0673368T3
DK0673368T3 DK93915075T DK93915075T DK0673368T3 DK 0673368 T3 DK0673368 T3 DK 0673368T3 DK 93915075 T DK93915075 T DK 93915075T DK 93915075 T DK93915075 T DK 93915075T DK 0673368 T3 DK0673368 T3 DK 0673368T3
Authority
DK
Denmark
Prior art keywords
saturated
carbon atoms
hitherto unknown
compounds
nicotinic esters
Prior art date
Application number
DK93915075T
Other languages
Danish (da)
English (en)
Inventor
Goeran Martens Vaeg Pettersson
Anders Bjoerk
Lisbeth Abramo
Curt Nordvi
Torbjoern Lundstedt
Gunnar Andersson
Wu Jin Chang
Catarina Ludwig
Elisabeth Seifert
Arne Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Application granted granted Critical
Publication of DK0673368T3 publication Critical patent/DK0673368T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK93915075T 1992-06-25 1993-06-23 Hidtil ukendte nicotinsyreestere DK0673368T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201956A SE9201956D0 (sv) 1992-06-25 1992-06-25 Novel nicotinicacid esters
PCT/SE1993/000565 WO1994000434A1 (en) 1992-06-25 1993-06-23 Novel nicotinic acid esters

Publications (1)

Publication Number Publication Date
DK0673368T3 true DK0673368T3 (da) 2002-03-18

Family

ID=20386602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93915075T DK0673368T3 (da) 1992-06-25 1993-06-23 Hidtil ukendte nicotinsyreestere

Country Status (27)

Country Link
US (1) US5658910A (es)
EP (2) EP0673368B1 (es)
JP (1) JP3306827B2 (es)
KR (1) KR100302216B1 (es)
CN (1) CN1085981C (es)
AT (2) ATE209634T1 (es)
AU (1) AU681346B2 (es)
BG (1) BG62000B1 (es)
CA (1) CA2139112C (es)
CZ (1) CZ281975B6 (es)
DE (2) DE69331234T2 (es)
DK (1) DK0673368T3 (es)
EE (1) EE03122B1 (es)
ES (1) ES2169044T3 (es)
FI (1) FI107151B (es)
HU (2) HU220613B1 (es)
IL (1) IL106135A (es)
NO (1) NO302945B1 (es)
NZ (1) NZ253823A (es)
PH (1) PH31417A (es)
PT (1) PT673368E (es)
RO (1) RO115725B1 (es)
RU (1) RU2127732C1 (es)
SE (1) SE9201956D0 (es)
SK (1) SK279393B6 (es)
WO (1) WO1994000434A1 (es)
ZA (1) ZA934596B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド グリコーゲンシンターゼキナーゼ3のインヒビター
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
BR112020022790A2 (pt) * 2018-05-09 2021-02-02 Lg Chem, Ltd novo composto que exibe atividade inibitória de enteropeptidase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
SE9202265D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel- pyridyl and pyrimidylpiperazine derivatives

Also Published As

Publication number Publication date
ZA934596B (en) 1994-02-14
HU210875A9 (en) 1995-08-28
SK279393B6 (sk) 1998-11-04
SK158594A3 (en) 1995-07-11
KR950702186A (ko) 1995-06-19
CA2139112C (en) 2006-03-21
JP3306827B2 (ja) 2002-07-24
PT673368E (pt) 2002-05-31
US5658910A (en) 1997-08-19
DE69331234D1 (de) 2002-01-10
SE9201956D0 (sv) 1992-06-25
JPH07508517A (ja) 1995-09-21
CN1085981C (zh) 2002-06-05
CZ281975B6 (cs) 1997-04-16
RO115725B1 (ro) 2000-05-30
AU4519393A (en) 1994-01-24
RU94046310A (ru) 1996-10-27
PH31417A (en) 1998-10-29
HU9403786D0 (en) 1995-02-28
DE69333655D1 (de) 2004-11-11
EP1120410A1 (en) 2001-08-01
IL106135A0 (en) 1993-10-20
FI946085A (fi) 1994-12-23
ATE209634T1 (de) 2001-12-15
NO945022L (no) 1995-02-13
KR100302216B1 (ko) 2001-11-22
RU2127732C1 (ru) 1999-03-20
WO1994000434A1 (en) 1994-01-06
DE69331234T2 (de) 2002-08-08
EP0673368A1 (en) 1995-09-27
EP1120410B1 (en) 2004-10-06
NO302945B1 (no) 1998-05-11
EP0673368B1 (en) 2001-11-28
FI107151B (fi) 2001-06-15
CA2139112A1 (en) 1994-01-06
HUT71406A (en) 1995-11-28
FI946085A0 (fi) 1994-12-23
NO945022D0 (no) 1994-12-23
HU220613B1 (hu) 2002-03-28
ES2169044T3 (es) 2002-07-01
CZ327494A3 (en) 1995-09-13
AU681346B2 (en) 1997-08-28
ATE278671T1 (de) 2004-10-15
EE03122B1 (et) 1998-10-15
IL106135A (en) 1999-01-26
NZ253823A (en) 1996-01-26
CN1086811A (zh) 1994-05-18
BG62000B1 (bg) 1998-12-30
BG99289A (bg) 1995-09-29

Similar Documents

Publication Publication Date Title
BG105254A (en) Heterocyclic compounds as inhibitors of rotamase enzymes
MX166257B (es) Composicion de revestimiento que contiene grupos de carbamato de hidroxialquilo
DE69133299D1 (de) Aminosulfonylcarbamate
ATE184000T1 (de) 2-oxindolderivate als tyrosinekinaseinhibitoren
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
DE3474444D1 (en) 1,3,4,5-tetrahydrobenzo(c,d)indoles, process for their preparation and their uses
DK0673368T3 (da) Hidtil ukendte nicotinsyreestere
DE69329084D1 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
ATE218538T1 (de) Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE140229T1 (de) Benzoxazepinon-verfahren
DE3867652D1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
ATE195728T1 (de) Pyridinderivate als hydroxylase- und lyase- inhibitoren
ES2140552T3 (es) Derivados indol como inhibidores de la 5-alfa-reductasa-1.
ATE30415T1 (de) Enkephalinas-inhibitoren.
NO179004C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazolderivater
DE68908761D1 (de) Monopersulfate von stickstoffenthaltenden heterocyclischen Polypercarbonsäuren.
GEP19971013B (en) Novel pyridyl and pyrimidyl derivatives process for preparing thereof, and treatment method for mental disorder
GB1212368A (en) Substituted s-triazines